SENSEX NIFTY

Accenture Technology Lab

May 25, 2016 at 12:47 | Source: CNBC-TV18
A regulatory body for labs could help the unorganised sector as well as help mitigate risks for companies, says A Velumani, Chairman, CEO & MD of the company.
May 20, 2016 at 18:57 | Source: CNBC-TV18
Dilip Bhat says that a combination of recent reforms like the Mauritius Treaty, P-Note amendment and a possible US Fed rate hike in June have been overwhelming for the market in the short term.
May 19, 2016 at 12:07 | Source: CNBC-TV18
The calm in the markets seen over last two months may be absent next month, says Edelweiss Securities CEO Vikas Khemani.
May 17, 2016 at 10:10 | Source: CNBC-TV18
Earnings have been better than expected this quarter, and would even accelerate going forward on the assumption that monsoon is good. Otherwise all bets are off, says Vibhav Kapoor of IL&FS.
May 10, 2016 at 13:22 | Source: CNBC-TV18
Deepak Shenoy of Capitalmind.in is of the view that Ujjivan Financial Services looks attractive.
May 10, 2016 at 07:30 | Source: PTI
Richard Verma, accompanied by other dignitaries, visited Tata Power Delhi Distribution's Smart Grid Lab in Rohini and Tata Power DDL's grid connected 225 KW Solar Power Plant in the vicinity.
May 09, 2016 at 11:29 | Source: CNBC-TV18
With a capex of Rs 75 crore, Thyrocare Technologies CEO A Velumani is confident of increasing its reach with 25 laboratories in the coming year. He expects the company to clock a CAGR of 25-35% in the next few years.
May 09, 2016 at 10:00 | Source: Moneycontrol.com
The initial public offering (IPO) of Thyrocare was oversubscribed 73.55 times in a price band of Rs 420-446. The issue was open for bidding from April 27-29.
May 05, 2016 at 13:26 | Source: CNBC-TV18
The IPOs of Thyrocare, TeamLease, Ujjivan Finance, Alkem Labs and Dr Lal Pathlabs were subscribed 73, 66, 41, 33 and 21 times respectively.
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.